Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-23-021518
Filing Date
2023-06-15
Accepted
2023-06-15 17:46:55
Documents
1
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2979
  Complete submission text file 0001493152-23-021518.txt   4303
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra Inc (Issuer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4500 GREAT AMERICA PKWY STE. 100 #29 SANTA CLARA CA 95054
Business Address
Salva Francisco D. (Reporting) CIK: 0001834051 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41705 | Film No.: 231018700